MSB 4.67% $1.07 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-813

  1. 1,900 Posts.
    lightbulb Created with Sketch. 303
    Certain people just can't accept the fact they got rejected. Now they need to accept the decision and move on and find a way to get it over the line as soon as possible.

    Mesoblast would be smart to get along with the FDA because getting GvHD isn't the end game. You will have to get many treatments approved by the FDA in the forseeable future. So having a 'trantrum' doesn't really help.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.053(4.67%)
Mkt cap ! $1.255B
Open High Low Value Volume
$1.14 $1.16 $1.07 $6.644M 6.019M

Buyers (Bids)

No. Vol. Price($)
34 234164 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.08 36875 14
View Market Depth
Last trade - 15.18pm 29/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.